Lorna Moore
Concepts (441)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Altitude | 80 | 2023 | 434 | 13.980 |
Why?
| Uterine Artery | 15 | 2022 | 67 | 5.260 |
Why?
| Fetal Growth Retardation | 30 | 2023 | 466 | 5.030 |
Why?
| Pre-Eclampsia | 16 | 2023 | 165 | 4.770 |
Why?
| Hypoxia | 35 | 2023 | 958 | 4.040 |
Why?
| Pregnancy | 72 | 2023 | 5521 | 3.600 |
Why?
| Acclimatization | 20 | 2019 | 150 | 3.460 |
Why?
| Fetal Hypoxia | 11 | 2022 | 47 | 3.370 |
Why?
| Uterus | 14 | 2020 | 192 | 3.240 |
Why?
| Altitude Sickness | 18 | 2022 | 172 | 2.770 |
Why?
| Placenta | 15 | 2023 | 624 | 2.420 |
Why?
| Placental Circulation | 8 | 2022 | 56 | 2.240 |
Why?
| Birth Weight | 22 | 2019 | 440 | 2.190 |
Why?
| Hypertension, Pregnancy-Induced | 5 | 2023 | 45 | 2.090 |
Why?
| Oxygen | 17 | 2023 | 855 | 2.040 |
Why?
| Adaptation, Physiological | 12 | 2021 | 481 | 1.950 |
Why?
| Vasodilation | 9 | 2022 | 417 | 1.940 |
Why?
| Arteries | 9 | 2022 | 249 | 1.850 |
Why?
| Fetal Development | 8 | 2022 | 247 | 1.830 |
Why?
| Bolivia | 19 | 2023 | 62 | 1.680 |
Why?
| Vasoconstriction | 4 | 2015 | 186 | 1.320 |
Why?
| AMP-Activated Protein Kinases | 6 | 2023 | 175 | 1.310 |
Why?
| Regional Blood Flow | 9 | 2015 | 428 | 1.140 |
Why?
| Selection, Genetic | 8 | 2019 | 243 | 1.110 |
Why?
| Female | 96 | 2023 | 59614 | 1.100 |
Why?
| Myometrium | 2 | 2020 | 35 | 1.090 |
Why?
| Nitric Oxide Synthase | 3 | 2019 | 209 | 1.050 |
Why?
| Fertility | 2 | 2021 | 130 | 1.000 |
Why?
| Oxygen Consumption | 15 | 2012 | 588 | 0.980 |
Why?
| Endothelium, Vascular | 4 | 2019 | 850 | 0.970 |
Why?
| HELLP Syndrome | 1 | 2023 | 6 | 0.900 |
Why?
| Biological Evolution | 5 | 2015 | 415 | 0.900 |
Why?
| Tibet | 14 | 2021 | 28 | 0.790 |
Why?
| Adult | 56 | 2021 | 30656 | 0.780 |
Why?
| Exercise | 8 | 2018 | 1644 | 0.770 |
Why?
| Pregnancy, Animal | 4 | 2006 | 52 | 0.760 |
Why?
| Humans | 102 | 2023 | 115044 | 0.760 |
Why?
| Muscle, Smooth, Vascular | 2 | 2019 | 417 | 0.760 |
Why?
| Vascular Resistance | 6 | 2020 | 337 | 0.750 |
Why?
| Hemoglobins | 8 | 2017 | 315 | 0.740 |
Why?
| Pregnancy Outcome | 4 | 2019 | 337 | 0.720 |
Why?
| Hemodynamics | 8 | 2021 | 1017 | 0.710 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.700 |
Why?
| Infant, Newborn | 21 | 2022 | 5041 | 0.670 |
Why?
| Pregnancy Complications | 6 | 2017 | 430 | 0.670 |
Why?
| Adrenergic alpha-Antagonists | 4 | 2003 | 30 | 0.670 |
Why?
| Polycythemia | 3 | 2017 | 23 | 0.650 |
Why?
| Maternal-Fetal Exchange | 4 | 2021 | 151 | 0.630 |
Why?
| Protein Kinases | 1 | 2020 | 307 | 0.610 |
Why?
| Maternal Health Services | 1 | 2019 | 78 | 0.600 |
Why?
| Catecholamines | 8 | 2003 | 96 | 0.550 |
Why?
| Menstrual Cycle | 7 | 2003 | 108 | 0.530 |
Why?
| Women's Health | 2 | 2011 | 271 | 0.530 |
Why?
| Gestational Age | 9 | 2021 | 758 | 0.520 |
Why?
| Infant, Small for Gestational Age | 3 | 2011 | 76 | 0.520 |
Why?
| Fetus | 5 | 2023 | 702 | 0.490 |
Why?
| Diabetes, Gestational | 1 | 2018 | 281 | 0.470 |
Why?
| Pulmonary Circulation | 2 | 2021 | 407 | 0.470 |
Why?
| Receptor, Endothelin A | 1 | 2014 | 59 | 0.470 |
Why?
| Aromatase | 1 | 2014 | 30 | 0.460 |
Why?
| Blood Pressure | 11 | 2020 | 1539 | 0.460 |
Why?
| Genetics, Population | 6 | 2010 | 190 | 0.450 |
Why?
| Polymorphism, Single Nucleotide | 10 | 2019 | 1901 | 0.430 |
Why?
| Endothelin-1 | 2 | 2020 | 167 | 0.430 |
Why?
| Ultrasonography, Doppler | 3 | 2020 | 105 | 0.420 |
Why?
| Health Services Accessibility | 1 | 2019 | 765 | 0.420 |
Why?
| Estrogens | 2 | 2014 | 313 | 0.410 |
Why?
| Indians, South American | 6 | 2015 | 22 | 0.410 |
Why?
| Respiratory Mechanics | 4 | 2007 | 57 | 0.410 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2012 | 58 | 0.410 |
Why?
| Phenylephrine | 6 | 2020 | 74 | 0.410 |
Why?
| PPAR gamma | 3 | 2020 | 184 | 0.410 |
Why?
| Sleep Apnea Syndromes | 1 | 2013 | 74 | 0.400 |
Why?
| Angiotensin II | 2 | 2011 | 91 | 0.400 |
Why?
| Infant, Low Birth Weight | 2 | 2011 | 125 | 0.400 |
Why?
| Genome, Human | 4 | 2012 | 351 | 0.390 |
Why?
| Gene Frequency | 5 | 2014 | 483 | 0.380 |
Why?
| Receptor, Angiotensin, Type 2 | 1 | 2011 | 8 | 0.380 |
Why?
| Enzymes | 1 | 2011 | 62 | 0.380 |
Why?
| Travel | 1 | 2012 | 121 | 0.380 |
Why?
| Homeostasis | 2 | 2014 | 578 | 0.370 |
Why?
| Nitric Oxide | 3 | 2020 | 827 | 0.370 |
Why?
| Prazosin | 5 | 2003 | 26 | 0.360 |
Why?
| Infant Mortality | 2 | 2021 | 91 | 0.360 |
Why?
| Angiostatic Proteins | 1 | 2010 | 5 | 0.360 |
Why?
| Animals | 22 | 2023 | 31867 | 0.360 |
Why?
| Angiogenic Proteins | 1 | 2010 | 18 | 0.360 |
Why?
| South America | 5 | 2017 | 51 | 0.360 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 66 | 0.340 |
Why?
| Young Adult | 10 | 2020 | 10498 | 0.330 |
Why?
| Interleukin-1beta | 1 | 2010 | 370 | 0.310 |
Why?
| Heart Rate | 7 | 2015 | 705 | 0.300 |
Why?
| Antioxidants | 1 | 2011 | 530 | 0.300 |
Why?
| Mountaineering | 2 | 2005 | 47 | 0.300 |
Why?
| Guinea Pigs | 6 | 2006 | 149 | 0.300 |
Why?
| Europe | 4 | 2009 | 336 | 0.280 |
Why?
| Oxidative Stress | 1 | 2013 | 1085 | 0.280 |
Why?
| Case-Control Studies | 5 | 2017 | 3015 | 0.270 |
Why?
| Cardiovascular Physiological Phenomena | 1 | 2005 | 40 | 0.260 |
Why?
| Acetylcholine | 2 | 2020 | 179 | 0.250 |
Why?
| Autonomic Nervous System | 1 | 2005 | 70 | 0.250 |
Why?
| Research | 2 | 2005 | 395 | 0.250 |
Why?
| Infant | 6 | 2021 | 7946 | 0.250 |
Why?
| Fetal Death | 2 | 2003 | 50 | 0.240 |
Why?
| Mice | 8 | 2021 | 14927 | 0.240 |
Why?
| Cytokines | 2 | 2010 | 1843 | 0.240 |
Why?
| Placental Insufficiency | 2 | 2023 | 102 | 0.230 |
Why?
| Embryonic and Fetal Development | 2 | 2003 | 94 | 0.230 |
Why?
| Mammals | 2 | 2022 | 245 | 0.230 |
Why?
| Norepinephrine | 3 | 2001 | 208 | 0.230 |
Why?
| Models, Genetic | 2 | 2007 | 566 | 0.230 |
Why?
| Chi-Square Distribution | 2 | 2018 | 498 | 0.230 |
Why?
| Peru | 2 | 2021 | 55 | 0.230 |
Why?
| Epinephrine | 3 | 2001 | 167 | 0.230 |
Why?
| Parity | 2 | 2018 | 98 | 0.220 |
Why?
| Chronic Disease | 7 | 2013 | 1591 | 0.220 |
Why?
| Blood Flow Velocity | 3 | 2011 | 390 | 0.220 |
Why?
| Interleukin-6 | 2 | 2010 | 676 | 0.220 |
Why?
| Mining | 1 | 2003 | 16 | 0.210 |
Why?
| Amino Acids | 3 | 2023 | 451 | 0.210 |
Why?
| Silver | 1 | 2003 | 27 | 0.210 |
Why?
| Speech Production Measurement | 1 | 2002 | 15 | 0.210 |
Why?
| Speech Disorders | 1 | 2002 | 30 | 0.210 |
Why?
| Receptors, Adrenergic, alpha-1 | 2 | 2001 | 41 | 0.210 |
Why?
| Geography | 3 | 2011 | 180 | 0.210 |
Why?
| Regression Analysis | 3 | 2018 | 948 | 0.200 |
Why?
| Progesterone | 5 | 2003 | 232 | 0.200 |
Why?
| Carbohydrate Metabolism | 2 | 2000 | 50 | 0.200 |
Why?
| Myoglobin | 1 | 2002 | 14 | 0.200 |
Why?
| Male | 26 | 2019 | 55731 | 0.200 |
Why?
| Trophoblasts | 2 | 2019 | 162 | 0.200 |
Why?
| Developing Countries | 1 | 2023 | 236 | 0.200 |
Why?
| Potassium Channels | 2 | 2022 | 121 | 0.200 |
Why?
| Erythropoiesis | 1 | 2001 | 34 | 0.200 |
Why?
| Motor Skills | 1 | 2002 | 81 | 0.190 |
Why?
| Adrenergic alpha-Agonists | 4 | 2003 | 29 | 0.190 |
Why?
| Gene Expression Regulation | 4 | 2021 | 2329 | 0.190 |
Why?
| Reproduction | 1 | 2003 | 179 | 0.190 |
Why?
| Glycolysis | 2 | 2021 | 227 | 0.190 |
Why?
| Luteal Phase | 5 | 2001 | 41 | 0.180 |
Why?
| Risk Factors | 5 | 2019 | 8643 | 0.180 |
Why?
| Aminoimidazole Carboxamide | 1 | 2020 | 10 | 0.180 |
Why?
| Pyrones | 1 | 2020 | 9 | 0.180 |
Why?
| Mice, Inbred C57BL | 5 | 2021 | 4718 | 0.180 |
Why?
| Hypertension, Pulmonary | 2 | 2022 | 1736 | 0.180 |
Why?
| Respiratory Physiological Phenomena | 1 | 2000 | 29 | 0.180 |
Why?
| Ribonucleotides | 1 | 2020 | 25 | 0.180 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 95 | 0.180 |
Why?
| Muscle Relaxation | 1 | 2000 | 28 | 0.180 |
Why?
| Reproductive Health | 1 | 2021 | 70 | 0.180 |
Why?
| Genotype | 4 | 2014 | 1780 | 0.170 |
Why?
| Biphenyl Compounds | 1 | 2020 | 50 | 0.170 |
Why?
| Arterial Pressure | 2 | 2017 | 99 | 0.170 |
Why?
| Respiratory Function Tests | 3 | 2013 | 523 | 0.170 |
Why?
| Genetic Markers | 3 | 2012 | 323 | 0.170 |
Why?
| Thiophenes | 1 | 2020 | 108 | 0.170 |
Why?
| Erythropoietin | 2 | 2017 | 72 | 0.170 |
Why?
| Vasoconstrictor Agents | 1 | 2020 | 112 | 0.170 |
Why?
| Neovascularization, Physiologic | 1 | 2021 | 173 | 0.170 |
Why?
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 20 | 0.160 |
Why?
| Biological Transport | 3 | 2019 | 372 | 0.160 |
Why?
| Blood Volume | 4 | 2007 | 59 | 0.160 |
Why?
| Estradiol | 5 | 2003 | 455 | 0.160 |
Why?
| Adrenergic beta-Antagonists | 1 | 2001 | 294 | 0.160 |
Why?
| Follicular Phase | 5 | 2001 | 36 | 0.160 |
Why?
| Health Promotion | 1 | 2005 | 686 | 0.160 |
Why?
| Blood Gas Analysis | 3 | 2007 | 74 | 0.160 |
Why?
| Intraocular Pressure | 1 | 2000 | 276 | 0.160 |
Why?
| Glyburide | 1 | 1998 | 35 | 0.160 |
Why?
| Adipose Tissue, White | 1 | 2018 | 33 | 0.160 |
Why?
| Delivery, Obstetric | 2 | 2011 | 118 | 0.160 |
Why?
| Cohort Studies | 4 | 2020 | 4904 | 0.160 |
Why?
| Sudden Infant Death | 1 | 1998 | 24 | 0.150 |
Why?
| Maternal Age | 1 | 2018 | 117 | 0.150 |
Why?
| Analysis of Variance | 3 | 2011 | 1229 | 0.150 |
Why?
| Body Weights and Measures | 2 | 2015 | 33 | 0.150 |
Why?
| Vasodilator Agents | 1 | 2020 | 307 | 0.150 |
Why?
| DNA | 2 | 2006 | 1352 | 0.150 |
Why?
| Glucose | 2 | 2023 | 900 | 0.150 |
Why?
| Respiration | 3 | 2005 | 182 | 0.150 |
Why?
| Ethiopia | 1 | 2017 | 31 | 0.150 |
Why?
| Physical Endurance | 2 | 2001 | 231 | 0.150 |
Why?
| Models, Biological | 4 | 2015 | 1636 | 0.150 |
Why?
| Cross-Sectional Studies | 4 | 2022 | 4411 | 0.150 |
Why?
| Ovariectomy | 1 | 1997 | 117 | 0.140 |
Why?
| Placenta Growth Factor | 2 | 2022 | 22 | 0.140 |
Why?
| Vascular Diseases | 2 | 2017 | 231 | 0.140 |
Why?
| Receptors, Erythropoietin | 1 | 2017 | 22 | 0.140 |
Why?
| Linear Models | 2 | 2014 | 776 | 0.140 |
Why?
| Time Factors | 8 | 2011 | 6141 | 0.140 |
Why?
| Pulmonary Gas Exchange | 2 | 2015 | 117 | 0.130 |
Why?
| Adolescent | 5 | 2019 | 17864 | 0.130 |
Why?
| Cardiovascular System | 1 | 2017 | 126 | 0.130 |
Why?
| Pregnancy Complications, Cardiovascular | 3 | 2007 | 64 | 0.130 |
Why?
| Lipid Metabolism | 1 | 2018 | 449 | 0.130 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2023 | 499 | 0.130 |
Why?
| Retrospective Studies | 4 | 2022 | 12547 | 0.120 |
Why?
| Electrocardiography | 1 | 1998 | 562 | 0.120 |
Why?
| Incidence | 2 | 2018 | 2318 | 0.120 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 225 | 0.120 |
Why?
| Double-Blind Method | 4 | 2003 | 1664 | 0.120 |
Why?
| Multivariate Analysis | 1 | 2018 | 1435 | 0.120 |
Why?
| Severity of Illness Index | 1 | 2002 | 2551 | 0.120 |
Why?
| Polymorphism, Genetic | 2 | 2012 | 617 | 0.120 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2015 | 184 | 0.120 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2021 | 450 | 0.120 |
Why?
| Receptor, Endothelin B | 1 | 2014 | 51 | 0.120 |
Why?
| Phenotype | 2 | 2023 | 2815 | 0.120 |
Why?
| Sex Characteristics | 5 | 2001 | 635 | 0.120 |
Why?
| Receptors, Endothelin | 1 | 2014 | 49 | 0.120 |
Why?
| In Vitro Techniques | 2 | 2011 | 1036 | 0.120 |
Why?
| Body Height | 2 | 2013 | 180 | 0.110 |
Why?
| Enzyme Inhibitors | 2 | 2012 | 752 | 0.110 |
Why?
| Hypertension | 3 | 2015 | 1058 | 0.110 |
Why?
| Body Weight | 3 | 2007 | 873 | 0.110 |
Why?
| Ultrasonography, Prenatal | 2 | 2013 | 235 | 0.110 |
Why?
| Gonadal Steroid Hormones | 1 | 2014 | 124 | 0.100 |
Why?
| Pulmonary Artery | 2 | 2015 | 1028 | 0.100 |
Why?
| Gene Regulatory Networks | 1 | 2014 | 229 | 0.100 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 38 | 0.100 |
Why?
| Pregnancy Trimesters | 1 | 2012 | 13 | 0.100 |
Why?
| Optic Atrophy, Hereditary, Leber | 1 | 2012 | 4 | 0.100 |
Why?
| Genetic Association Studies | 1 | 2014 | 344 | 0.100 |
Why?
| Prevalence | 1 | 2018 | 2255 | 0.100 |
Why?
| Polysomnography | 1 | 2013 | 135 | 0.100 |
Why?
| Indomethacin | 1 | 2012 | 75 | 0.100 |
Why?
| NADH Dehydrogenase | 1 | 2012 | 17 | 0.100 |
Why?
| Middle Aged | 5 | 2019 | 26827 | 0.100 |
Why?
| Reference Values | 4 | 2003 | 748 | 0.100 |
Why?
| Age Factors | 2 | 2011 | 2894 | 0.100 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2012 | 72 | 0.100 |
Why?
| Lactic Acid | 3 | 2023 | 278 | 0.100 |
Why?
| Colorado | 5 | 2019 | 4089 | 0.100 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2014 | 358 | 0.100 |
Why?
| Apgar Score | 1 | 2011 | 16 | 0.100 |
Why?
| DNA Methylation | 1 | 2015 | 496 | 0.100 |
Why?
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2011 | 3 | 0.100 |
Why?
| Population Dynamics | 1 | 2012 | 128 | 0.090 |
Why?
| Potassium Chloride | 1 | 2011 | 35 | 0.090 |
Why?
| Atmospheric Pressure | 2 | 2001 | 18 | 0.090 |
Why?
| Signal Transduction | 2 | 2021 | 4525 | 0.090 |
Why?
| Laser-Doppler Flowmetry | 1 | 2011 | 32 | 0.090 |
Why?
| Live Birth | 1 | 2011 | 48 | 0.090 |
Why?
| Child Development | 1 | 2015 | 389 | 0.090 |
Why?
| Iliac Artery | 1 | 2011 | 44 | 0.090 |
Why?
| DNA, Mitochondrial | 1 | 2012 | 183 | 0.090 |
Why?
| Stillbirth | 1 | 2011 | 57 | 0.090 |
Why?
| Ultrasonography | 1 | 2014 | 636 | 0.090 |
Why?
| Confidence Intervals | 1 | 2011 | 306 | 0.090 |
Why?
| Alleles | 3 | 2012 | 792 | 0.090 |
Why?
| Pregnancy Proteins | 1 | 2010 | 36 | 0.090 |
Why?
| Genomics | 2 | 2023 | 641 | 0.090 |
Why?
| Sympathetic Nervous System | 2 | 2003 | 171 | 0.090 |
Why?
| Haplotypes | 3 | 2017 | 455 | 0.090 |
Why?
| Renal Circulation | 3 | 1998 | 53 | 0.090 |
Why?
| Sheep | 2 | 2023 | 764 | 0.090 |
Why?
| Anthropology, Physical | 1 | 2009 | 27 | 0.090 |
Why?
| Interleukin-4 | 1 | 2010 | 209 | 0.080 |
Why?
| Mesenteric Arteries | 2 | 2000 | 16 | 0.080 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 254 | 0.080 |
Why?
| Databases, Genetic | 1 | 2010 | 206 | 0.080 |
Why?
| Pedigree | 1 | 2010 | 467 | 0.080 |
Why?
| Lung Diseases | 1 | 2015 | 703 | 0.080 |
Why?
| Ovary | 2 | 2018 | 191 | 0.080 |
Why?
| Up-Regulation | 1 | 2011 | 812 | 0.080 |
Why?
| Interleukin-10 | 1 | 2010 | 297 | 0.080 |
Why?
| Exercise Test | 3 | 2001 | 545 | 0.080 |
Why?
| Transcription, Genetic | 1 | 2014 | 1317 | 0.080 |
Why?
| Lung | 1 | 2021 | 3595 | 0.080 |
Why?
| Basal Metabolism | 3 | 2003 | 46 | 0.080 |
Why?
| Prospective Studies | 3 | 2022 | 6232 | 0.080 |
Why?
| Head | 1 | 2008 | 85 | 0.070 |
Why?
| Premature Birth | 1 | 2011 | 278 | 0.070 |
Why?
| Heart Rate, Fetal | 1 | 2007 | 20 | 0.070 |
Why?
| Biometry | 1 | 2007 | 63 | 0.070 |
Why?
| Femur | 1 | 2008 | 193 | 0.070 |
Why?
| Indians, North American | 2 | 2009 | 570 | 0.070 |
Why?
| Urban Health | 1 | 2007 | 73 | 0.070 |
Why?
| Aorta, Thoracic | 2 | 2000 | 257 | 0.070 |
Why?
| Health Status | 1 | 2011 | 722 | 0.070 |
Why?
| Phylogeny | 2 | 2010 | 796 | 0.070 |
Why?
| Disease Models, Animal | 3 | 2021 | 3545 | 0.070 |
Why?
| Longitudinal Studies | 3 | 2019 | 2389 | 0.070 |
Why?
| Chromosome Mapping | 1 | 2007 | 490 | 0.070 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 102 | 0.060 |
Why?
| Surveys and Questionnaires | 2 | 2011 | 4631 | 0.060 |
Why?
| Mental Health | 1 | 2011 | 559 | 0.060 |
Why?
| Genetic Predisposition to Disease | 2 | 2012 | 2108 | 0.060 |
Why?
| Serum | 1 | 2006 | 57 | 0.060 |
Why?
| Hypoxia-Inducible Factor 1 | 1 | 2006 | 68 | 0.060 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2010 | 1138 | 0.060 |
Why?
| Hyperplasia | 1 | 2006 | 165 | 0.060 |
Why?
| Cell Count | 1 | 2006 | 304 | 0.060 |
Why?
| History, 21st Century | 1 | 2005 | 161 | 0.060 |
Why?
| Adrenergic alpha-1 Receptor Antagonists | 2 | 2001 | 18 | 0.060 |
Why?
| Child | 4 | 2015 | 18407 | 0.060 |
Why?
| History, 20th Century | 1 | 2005 | 267 | 0.060 |
Why?
| Gene-Environment Interaction | 2 | 2017 | 185 | 0.060 |
Why?
| Gene Expression Profiling | 1 | 2010 | 1523 | 0.060 |
Why?
| Plasma Volume | 1 | 2003 | 13 | 0.060 |
Why?
| Cardiac Output | 3 | 1998 | 143 | 0.060 |
Why?
| Lower Extremity | 1 | 2007 | 337 | 0.060 |
Why?
| Biomechanical Phenomena | 1 | 2006 | 675 | 0.050 |
Why?
| Pyruvates | 1 | 2023 | 20 | 0.050 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 249 | 0.050 |
Why?
| Acute Disease | 2 | 2005 | 915 | 0.050 |
Why?
| Embryo Implantation | 1 | 2003 | 23 | 0.050 |
Why?
| Primary Prevention | 1 | 2005 | 171 | 0.050 |
Why?
| History, 17th Century | 1 | 2003 | 15 | 0.050 |
Why?
| Ion Channels | 1 | 2023 | 124 | 0.050 |
Why?
| Glutamine | 1 | 2023 | 91 | 0.050 |
Why?
| Blood Glucose | 3 | 2001 | 1821 | 0.050 |
Why?
| Sound Spectrography | 1 | 2002 | 25 | 0.050 |
Why?
| Speech Acoustics | 1 | 2002 | 11 | 0.050 |
Why?
| Ischemia | 1 | 2006 | 363 | 0.050 |
Why?
| Serine | 1 | 2023 | 126 | 0.050 |
Why?
| Locomotion | 1 | 2003 | 81 | 0.050 |
Why?
| Glycine | 1 | 2023 | 153 | 0.050 |
Why?
| Muscle Fatigue | 2 | 2001 | 94 | 0.050 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2022 | 61 | 0.050 |
Why?
| Cesarean Section | 1 | 2023 | 169 | 0.050 |
Why?
| Insulin | 3 | 2001 | 2082 | 0.050 |
Why?
| Partial Pressure | 1 | 2001 | 30 | 0.050 |
Why?
| Anaerobic Threshold | 1 | 2001 | 22 | 0.050 |
Why?
| Species Specificity | 1 | 2003 | 548 | 0.050 |
Why?
| C-Peptide | 2 | 2001 | 138 | 0.050 |
Why?
| Health Education | 1 | 2005 | 323 | 0.050 |
Why?
| Plethysmography | 1 | 2001 | 104 | 0.050 |
Why?
| Veins | 1 | 2001 | 57 | 0.050 |
Why?
| Pyruvic Acid | 1 | 2021 | 42 | 0.050 |
Why?
| Forearm | 1 | 2001 | 114 | 0.050 |
Why?
| Disease Susceptibility | 1 | 2003 | 316 | 0.050 |
Why?
| Muscle, Skeletal | 2 | 2001 | 1477 | 0.050 |
Why?
| Risk Assessment | 1 | 2010 | 2976 | 0.050 |
Why?
| Ventricular Pressure | 1 | 2021 | 37 | 0.050 |
Why?
| Exons | 1 | 2002 | 301 | 0.050 |
Why?
| Hyperbaric Oxygenation | 1 | 2021 | 36 | 0.050 |
Why?
| Genetic Variation | 1 | 2006 | 876 | 0.050 |
Why?
| Posture | 1 | 2001 | 153 | 0.050 |
Why?
| Cross-Over Studies | 1 | 2002 | 441 | 0.050 |
Why?
| Thoracic Arteries | 1 | 2000 | 4 | 0.050 |
Why?
| Asia | 1 | 2000 | 53 | 0.040 |
Why?
| Tonometry, Ocular | 1 | 2000 | 83 | 0.040 |
Why?
| Adenosine Triphosphate | 1 | 2022 | 431 | 0.040 |
Why?
| Bromodeoxyuridine | 1 | 2000 | 72 | 0.040 |
Why?
| Muscle Contraction | 2 | 2001 | 399 | 0.040 |
Why?
| Carbon Dioxide | 1 | 2001 | 218 | 0.040 |
Why?
| Paleontology | 1 | 2000 | 20 | 0.040 |
Why?
| Fetal Weight | 1 | 2000 | 52 | 0.040 |
Why?
| Archaeology | 1 | 2000 | 26 | 0.040 |
Why?
| Linguistics | 1 | 2000 | 26 | 0.040 |
Why?
| Endothelium | 1 | 2000 | 112 | 0.040 |
Why?
| Geographic Mapping | 1 | 2019 | 21 | 0.040 |
Why?
| North America | 1 | 2000 | 259 | 0.040 |
Why?
| Organ Size | 1 | 2000 | 444 | 0.040 |
Why?
| Nitroarginine | 1 | 1998 | 48 | 0.040 |
Why?
| Thiazolidinediones | 1 | 2020 | 143 | 0.040 |
Why?
| Ventricular Function, Right | 1 | 2021 | 252 | 0.040 |
Why?
| Litter Size | 1 | 1998 | 16 | 0.040 |
Why?
| Potassium Channel Blockers | 1 | 1998 | 29 | 0.040 |
Why?
| Cell Division | 1 | 2000 | 758 | 0.040 |
Why?
| Glucagon | 1 | 2018 | 93 | 0.040 |
Why?
| Gene Expression | 1 | 2023 | 1423 | 0.040 |
Why?
| Cells, Cultured | 1 | 2006 | 3896 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 370 | 0.040 |
Why?
| Hormones | 1 | 1998 | 132 | 0.040 |
Why?
| Carotid Sinus | 1 | 1997 | 2 | 0.040 |
Why?
| Adrenal Glands | 1 | 1998 | 67 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2002 | 1715 | 0.040 |
Why?
| Glomerular Filtration Rate | 2 | 1998 | 604 | 0.040 |
Why?
| Genome-Wide Association Study | 2 | 2017 | 1203 | 0.040 |
Why?
| Child, Preschool | 2 | 2015 | 9093 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2018 | 214 | 0.040 |
Why?
| Hypertrophy, Right Ventricular | 1 | 1998 | 141 | 0.040 |
Why?
| Infusions, Intravenous | 1 | 1998 | 372 | 0.040 |
Why?
| Chemoreceptor Cells | 1 | 1997 | 55 | 0.040 |
Why?
| Cats | 1 | 1997 | 205 | 0.040 |
Why?
| China | 1 | 1997 | 163 | 0.040 |
Why?
| Glucose Tolerance Test | 1 | 2018 | 344 | 0.040 |
Why?
| Energy Intake | 1 | 2000 | 421 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 551 | 0.040 |
Why?
| Ferritins | 1 | 2017 | 52 | 0.040 |
Why?
| Phosphorylation | 1 | 2021 | 1572 | 0.030 |
Why?
| Anesthesia | 1 | 1997 | 118 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2020 | 1634 | 0.030 |
Why?
| California | 1 | 2017 | 364 | 0.030 |
Why?
| Renin-Angiotensin System | 2 | 2010 | 71 | 0.030 |
Why?
| Energy Metabolism | 1 | 2000 | 729 | 0.030 |
Why?
| Pulmonary Veins | 1 | 2015 | 85 | 0.030 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 797 | 0.030 |
Why?
| Aged | 2 | 2017 | 19119 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2015 | 496 | 0.030 |
Why?
| Latin America | 1 | 2012 | 69 | 0.020 |
Why?
| Epigenesis, Genetic | 1 | 2015 | 524 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2012 | 262 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2015 | 1081 | 0.020 |
Why?
| Globins | 1 | 2010 | 22 | 0.020 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2010 | 26 | 0.020 |
Why?
| Thumb | 2 | 2001 | 25 | 0.020 |
Why?
| DNA Copy Number Variations | 1 | 2010 | 156 | 0.020 |
Why?
| Hydrocortisone | 2 | 2002 | 267 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2012 | 728 | 0.020 |
Why?
| Prognosis | 1 | 2017 | 3334 | 0.020 |
Why?
| Cyclic GMP | 2 | 1998 | 78 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2017 | 4420 | 0.020 |
Why?
| Aging | 1 | 1998 | 1624 | 0.020 |
Why?
| Indians, Central American | 1 | 2007 | 5 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2012 | 2796 | 0.020 |
Why?
| Chromosomes, Human | 1 | 2007 | 39 | 0.020 |
Why?
| Biomarkers | 1 | 2017 | 3419 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6357 | 0.020 |
Why?
| Genetic Linkage | 1 | 2007 | 297 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2012 | 2715 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 744 | 0.020 |
Why?
| Heart Failure | 1 | 2017 | 1962 | 0.020 |
Why?
| Genetic Testing | 1 | 2007 | 380 | 0.010 |
Why?
| International Cooperation | 1 | 2005 | 172 | 0.010 |
Why?
| Tilt-Table Test | 1 | 2001 | 6 | 0.010 |
Why?
| Placebos | 1 | 2001 | 198 | 0.010 |
Why?
| Societies, Medical | 1 | 2005 | 678 | 0.010 |
Why?
| Dietary Carbohydrates | 1 | 2001 | 136 | 0.010 |
Why?
| Water-Electrolyte Balance | 1 | 2000 | 26 | 0.010 |
Why?
| Fasting | 1 | 2001 | 242 | 0.010 |
Why?
| Transducers, Pressure | 1 | 1999 | 14 | 0.010 |
Why?
| Electric Stimulation | 1 | 1999 | 261 | 0.010 |
Why?
| Nitrogen | 1 | 2000 | 148 | 0.010 |
Why?
| Electrolytes | 1 | 1998 | 55 | 0.010 |
Why?
| Pregnancy Trimester, First | 1 | 1998 | 126 | 0.010 |
Why?
| Renin | 1 | 1997 | 31 | 0.010 |
Why?
| Atrial Natriuretic Factor | 1 | 1997 | 57 | 0.010 |
Why?
| Aldosterone | 1 | 1997 | 42 | 0.010 |
Why?
| Bicarbonates | 1 | 1997 | 41 | 0.010 |
Why?
| Nitrates | 1 | 1997 | 72 | 0.010 |
Why?
| Nitrites | 1 | 1997 | 74 | 0.010 |
Why?
| Chlorides | 1 | 1997 | 127 | 0.010 |
Why?
| Cyclic AMP | 1 | 1997 | 226 | 0.010 |
Why?
| Sodium | 1 | 1997 | 183 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2000 | 926 | 0.010 |
Why?
| Body Composition | 1 | 2000 | 586 | 0.010 |
Why?
| Poverty | 1 | 1999 | 443 | 0.010 |
Why?
| Insulin Resistance | 1 | 2001 | 1077 | 0.010 |
Why?
|
|
Moore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|